Sio Capital Management as of Sept. 30, 2021
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 61 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cigna Corp (CI) | 8.8 | $28M | 138k | 200.16 | |
| Curis Com New | 7.3 | $23M | 2.9M | 7.83 | |
| Spdr Gold Shares Gold Shs (GLD) | 5.4 | $17M | 103k | 164.22 | |
| Soliton | 5.4 | $17M | 825k | 20.36 | |
| Universal Health Services CL B (UHS) | 4.5 | $14M | 101k | 138.37 | |
| Hca Holdings (HCA) | 4.4 | $14M | 56k | 242.73 | |
| Galapagos Nv Spon Adr (GLPG) | 3.8 | $12M | 225k | 52.61 | |
| Aveanna Healthcare Hldgs (AVAH) | 3.6 | $11M | 1.4M | 8.02 | |
| Centene Corporation (CNC) | 3.6 | $11M | 179k | 62.31 | |
| United Therapeutics Corporation (UTHR) | 3.5 | $11M | 59k | 184.58 | |
| Merck & Co (MRK) | 3.0 | $9.4M | 125k | 75.11 | |
| Herbalife Nutrition Com Shs (HLF) | 2.9 | $9.2M | 216k | 42.38 | |
| McKesson Corporation (MCK) | 2.8 | $8.7M | 44k | 199.37 | |
| Cardinal Health (CAH) | 2.2 | $7.0M | 141k | 49.46 | |
| Renovacor | 2.1 | $6.7M | 736k | 9.05 | |
| Albireo Pharma | 2.1 | $6.7M | 214k | 31.20 | |
| Mirum Pharmaceuticals (MIRM) | 1.6 | $5.0M | 249k | 19.92 | |
| Integer Hldgs (ITGR) | 1.6 | $4.9M | 55k | 89.34 | |
| Healthequity (HQY) | 1.5 | $4.8M | 74k | 64.76 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.5 | $4.6M | 26k | 181.37 | |
| Gilead Sciences (GILD) | 1.5 | $4.6M | 66k | 69.85 | |
| Kura Oncology (KURA) | 1.4 | $4.3M | 228k | 18.73 | |
| X4 Pharmaceuticals (XFOR) | 1.4 | $4.3M | 805k | 5.29 | |
| Cross Country Healthcare (CCRN) | 1.4 | $4.2M | 200k | 21.24 | |
| Viking Therapeutics (VKTX) | 1.3 | $4.1M | 661k | 6.28 | |
| Syros Pharmaceuticals | 1.3 | $4.0M | 901k | 4.47 | |
| Spruce Biosciences (SPRB) | 1.2 | $3.6M | 603k | 6.01 | |
| Ayala Pharmaceuticals Incorporated | 1.2 | $3.6M | 319k | 11.34 | |
| Aeglea Biotherapeutics | 1.1 | $3.5M | 446k | 7.95 | |
| Rigel Pharmaceuticals Com New (RIGL) | 1.1 | $3.3M | 914k | 3.63 | |
| Neubase Therapeutics Ord | 1.0 | $3.3M | 906k | 3.61 | |
| Horizon Therapeutics SHS | 1.0 | $3.2M | 29k | 109.55 | |
| Moleculin Biotech | 1.0 | $3.1M | 1.0M | 3.00 | |
| Radius Health Com New | 1.0 | $3.0M | 242k | 12.41 | |
| Precision Biosciences Ord | 0.9 | $3.0M | 257k | 11.54 | |
| Catalyst Biosciences Com New | 0.8 | $2.6M | 624k | 4.11 | |
| Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 0.8 | $2.5M | 249k | 9.95 | |
| Health Sciences Acquisitions Corp 2 Ord Shs | 0.8 | $2.5M | 250k | 9.89 | |
| Aslan Pharmaceuticals Ads | 0.7 | $2.3M | 1.3M | 1.78 | |
| Cyclacel Pharmaceuticals | 0.7 | $2.2M | 423k | 5.27 | |
| Sierra Oncology Com New | 0.7 | $2.1M | 96k | 21.92 | |
| Fusion Pharmaceuticals (FUSN) | 0.7 | $2.1M | 260k | 7.92 | |
| Cymabay Therapeutics | 0.7 | $2.1M | 562k | 3.65 | |
| Cortexyme Put Option (QNCX) | 0.6 | $2.0M | 22k | 91.67 | |
| Leap Therapeutics | 0.6 | $1.8M | 440k | 4.01 | |
| Vincerx Pharma Com New (VINC) | 0.5 | $1.6M | 102k | 16.17 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $1.6M | 90k | 17.72 | |
| Evelo Biosciences Put Option | 0.5 | $1.5M | 206k | 7.04 | |
| Salarius Pharmaceuticals Com New | 0.4 | $1.4M | 1.4M | 1.02 | |
| Arena Pharmaceuticals Com New | 0.4 | $1.3M | 22k | 59.53 | |
| Mei Pharma Com New | 0.4 | $1.2M | 426k | 2.76 | |
| Natus Medical | 0.3 | $987k | 39k | 25.08 | |
| Logicbio Therapeutics | 0.3 | $836k | 183k | 4.58 | |
| Ardelyx (ARDX) | 0.2 | $755k | 572k | 1.32 | |
| Nyxoah Sa SHS (NYXH) | 0.2 | $477k | 16k | 29.25 | |
| Caremax Com Cl A | 0.1 | $297k | 31k | 9.66 | |
| Neoleukin Therapeutics | 0.1 | $277k | 38k | 7.23 | |
| Renovacor *w Exp 99/99/999 | 0.1 | $274k | 400k | 0.69 | |
| Humacyte *w Exp 09/21/202 (HUMAW) | 0.0 | $145k | 50k | 2.90 | |
| Rubius Therapeutics | 0.0 | $111k | 6.2k | 17.90 | |
| Caremax W Exp 06/08/2026 (CMAXW) | 0.0 | $36k | 13k | 2.81 |
